CROee supported Phase Ⅲ global clinical study
CROee supported Phase Ⅲ global clinical study for chronic lower back pain and osteoarthritis, achieving the target number of cases in Japan. CROee, Inc (Headquarters: Toshima-ku, Tokyo President: Sho Ando) contributed to the achievement of enrollment goals for a phase 3 global study sponsored by Pfizer Inc. (Headquarters: Tokyo, President: Akihisa Harada) by providing patients […]